NICOLET ADVISORY SERVICES, LLC - ZIOPHARM ONCOLOGY INC ownership

Quarter-by-quarter ownership
NICOLET ADVISORY SERVICES, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$2,356
-77.3%
21,5000.0%0.00%
-100.0%
Q2 2023$10,389
-19.5%
21,5000.0%0.00%0.0%
Q1 2023$12,900
-17.4%
21,5000.0%0.00%
-50.0%
Q4 2022$15,615
-49.6%
21,5000.0%0.00%
-60.0%
Q3 2022$31,000
+3.3%
21,5000.0%0.01%
+25.0%
Q2 2022$30,000
+172.7%
21,5000.0%0.00%
+300.0%
Q1 2022$11,000
-52.2%
21,5000.0%0.00%
-66.7%
Q4 2021$23,000
-41.0%
21,5000.0%0.00%
-40.0%
Q3 2021$39,000
-31.6%
21,5000.0%0.01%
-28.6%
Q2 2021$57,000
-26.0%
21,5000.0%0.01%
-36.4%
Q1 2021$77,000
+35.1%
21,500
-4.7%
0.01%
+37.5%
Q4 2020$57,0000.0%22,5550.0%0.01%
-11.1%
Q3 2020$57,00022,5550.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
Third Security, LLC 17,815,708$47,033,0002.93%
Essex Woodlands Management, Inc. 2,764,908$7,130,0002.60%
Belmont Global Advisors, Inc. 973,000$2,569,0002.01%
Belmont Global Advisors, Inc. 135,700$358,0000.28%
MSD Partners, L.P. 2,750,000$7,260,0000.22%
SFMG, LLC 99,850$264,0000.08%
Rotella Capital Management, Inc. 11,090$29,0000.03%
WESTPORT RESOURCES MANAGEMENT INC 33,500$88,0000.02%
SMITH ASSET MANAGEMENT GROUP LP 236,590$625,0000.02%
FRANKLIN STREET ADVISORS INC /NC 41,150$109,0000.02%
View complete list of ZIOPHARM ONCOLOGY INC shareholders